Select Medical (SEM) Stock
US provider of specialty hospitals and rehabilitation facilities. Here's the price, business snapshot, and what's worth knowing about Select Medical in September 2026.
Select Medical Holdings Corporation (SEM) is a US-based provider of post‑acute healthcare services, operating speciality hospitals, long‑term acute care and inpatient rehabilitation facilities, alongside outpatient physical therapy clinics. With a market capitalisation of about $1.71 billion, the company’s performance is driven by occupancy levels, payer reimbursement rates and partnerships with health systems and insurers. Investors should note the business benefits from secular trends such as an ageing population and rising demand for post‑acute care, plus growth through acquisitions and joint ventures. At the same time SEM is exposed to regulatory and reimbursement risk, labour cost pressures, and cyclical patient volumes—which can affect margins and cash flow. This summary is educational and not personal investment advice; potential investors should assess their own objectives, tolerance for health‑sector regulatory risk and consult a qualified adviser before acting.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts suggest holding Select Medical's stock as its target price is slightly lower than its current price.
Financial Health
Select Medical is performing well with solid revenue and cash flow, indicating good financial stability.
Dividend
Select Medical's dividend yield of 1.52% is lower than many investors might prefer. If you invested $1000 you would be paid $15.20 a year in dividends (based on the last 12 months).
Why You’ll Want to Watch This Stock
Post‑acute demand
Ageing populations and more complex chronic care can push demand for rehabilitation and long‑term acute services, though volumes can vary with hospital referrals and economic cycles.
Partnerships & network
Select Medical’s joint ventures and network scale help access referrals and negotiate with payers, but integration and contractual terms influence outcomes and margins.
Reimbursement sensitivity
Profitability is sensitive to Medicare and private payer rates and to labour costs—regulatory or policy changes could materially affect earnings.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
